NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) (the Company), today announced that it is commencing an underwritten public offering of shares of its common stock. In addition, the Company intends to grant the underwriters an option for a period…
